What is EXOZ's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for EXOZ?

P/E (TTM) is n/a and 52-week range is $4.35 to $18.40 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s EXOZ figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for EXOZ?

The company profile lists net income (TTM) near $-11M, EPS (TTM) near $-1.20 when available from the market-data feed. Figures are informational and may lag live markets.

Where is eXoZymes Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Monrovia California, California, US, 9.3M shares outstanding, ISIN US4618741098 when available from company profile and filing metadata.

eXoZymes Inc

$EXOZ

Health Care · Biotechnology

Run Scenarios

$5.25

-0.38%

eXoZymes Inc

$EXOZ

Health Care · Biotechnology

Run Scenarios

$5.25

-0.38%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Employees

32

Website

exozymes.com/

IPO

2024-11-13

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US4618741098

Headquarters

Monrovia California, California, US

Shares outstanding

9.3M

NAICS sector

Professional, Scientific, and Technical Services

Institutional ownership

1.34%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Employees

32

Website

exozymes.com/

IPO

2024-11-13

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)